Musculoskeletal Science

Aug 25, 2024 | bmccancer.biomedcentral.com | Chiang Mai |Musculoskeletal Science

This study has been granted approval by the Ethics Committee of the Faculty of Medicine, Chiang Mai University [RAD-2565–09175]. The need for informed consent was waived owing to the retrospective nature of data collection. The electronic medical database was searched from January 2012 to December 2021. The inclusion criteria were patients who were at least 18 years old and diagnosed with rHCC.

Aug 25, 2024 | link.springer.com | Chiang Mai |Musculoskeletal Science

AbstractSpontaneous rupture of hepatocellular carcinoma (rHCC) poses a life-threatening complication with a mortality rate of 25–75%. Treatment aims at achieving hemostasis and includes options such as trans-arterial embolization, perihepatic packing, and hepatic resection. The optimal treatment remains a subject of debate. Our retrospective review evaluates these treatments and investigates imaging’s role in prognosis for rHCC patients.

Jan 13, 2024 | academic.oup.com | Musculoskeletal Science

To understand the relative efficacy and safety of bimekizumab, a selective inhibitor of interleukin-17F in addition to IL-17A, vs other biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for psoriatic arthritis (PsA) using network meta-analysis (NMA). A systematic literature review (most recent update conducted on 01 January 2023) identified randomised controlled trials (RCTs) of b/tsDMARDs in PsA.

Jul 25, 2023 | frontiersin.org | Brunel London |Manchester Metropolitan |Musculoskeletal Science

Carla Harkness-Armstrong1 Emma F.

Apr 5, 2023 | trialsjournal.biomedcentral.com | Musculoskeletal Science |Kings College London

This trial aims to investigate whether the administration of hydroxychloroquine in addition to standard of care maintenance therapy can improve the clinical response of AAV by moderating disease activity, reducing disease flares and preventing disease progression, culminating in an improved quality of life for patients with this disease. The importance of developing additional treatment options for AAV cannot be understated.